Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at avelumab for peripheral T cell lymphoma that had come back or where treatment had stopped working.
The trial was open for people to join between 2017 and 2019. The team presented the results at a conference in 2020.
Recruitment start: 14 November 2017
Recruitment end: 14 November 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Simon Wagner
Bloodwise
Pfizer
University of Birmingham
Last reviewed: 30 April 2024
CRUK internal database number: 15562
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
